The crucial role of CD37 in B cell lymphoma formation comes from a murine model, where CD37-deficient mice spontaneously developed germinal center–derived B cell lymphoma in lymph nodes and spleens with a higher incidence than Bcl2 transgenic mice (50% vs. 20%) [45]. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.